$1.660
-0.030 (-1.78%)Zum Schluss
OSTX im Vergleich zur Peergroup
In the context of the broader market, OSTX competes directly with industry leaders such as GANX and LONA. With a market capitalization of $74.72M, it holds a significant position in the sector. When comparing efficiency, OSTX's gross margin of N/A stands against GANX's N/A and LONA's N/A. Such benchmarking helps identify whether OS Therapies Inc is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von OS Therapies Inc
The company has reported consistent net losses, with Q1 2026 showing a net operating loss of $10.4 million, a 167% increase from the previous year, indicating significant challenges in achieving profitability.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.